Stock Runners: Piedmont Natural Gas Co. Inc. (NYSE:PNY), Quanta Services, Inc. (NYSE:PWR), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Acxiom Corporation (NASDAQ:ACXM),

Piedmont Natural Gas Inc. (NYSE:PNY) will sell its remaining stake in SouthStar Energy Services to Georgia Natural Gas Co. for $160 million, subject to Piedmont’s own sale to Duke Energy later this year.

Piedmont Natural Gas Co. Inc. (NYSE:PNY) belongs to Utilities sector. Its net profit margin is 10.00% and weekly performance is 0.32%. On last trading day company shares ended up at $59.53.

Quanta Services, Inc. (NYSE:PWR) announced results for the three and twelve months ended December 31, 2015. Revenues in the fourth quarter of 2015 were $1.90 billion compared to revenues of $2.03 billion in the fourth quarter of 2014. Net loss from continuing operations attributable to common stock was $2.6 million, or a loss of $0.02 per diluted share, in the fourth quarter of 2015 compared to net income from continuing operations attributable to common stock of $60.4 million, or $0.27 per diluted share, in the fourth quarter of 2014.

Quanta Services, Inc. (NYSE:PWR) shares advanced 7.56% in last trading session and ended the day at $19.92. PWR Gross Margin is 13.40% and its return on assets is 6.40%. Quanta Services, Inc. (NYSE:PWR) quarterly performance is -6.96%.

La Jolla Pharmaceutical Co. (NASDAQ:LJPC) had $126.5 million in cash and cash equivalents, compared to $48.6 million as of December 31, 2014. The increase in cash and cash equivalents was primarily due to cash provided by our common stock offering that was completed in September 2015, which was partially offset by net cash used for operating activities. Based on current operating plans and projections, La Jolla believes that its current cash and cash equivalents are sufficient to fund operations into 2018.

On 25 February, La Jolla Pharmaceutical Co. (NASDAQ:LJPC) shares decreased -6.97% and was closed at $15.48. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) year to date (YTD) performance is -42.67%.

Acxiom Corporation (NASDAQ:ACXM) announced that Acxiom CFO Warren Jenson and LiveRamp COO James Arra will present at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, CA, on Wednesday, March 2, 2016, at 11:00 a.m. PST.

Acxiom Corporation (NASDAQ:ACXM) ended the last trading day at $20.29. Company weekly volatility is calculated as 2.46% and price to cash ratio as 8.46. Acxiom Corporation (NASDAQ:ACXM) showed a weekly performance of 1.86%.

On 23 February, Sanofi SA (ADR) (NYSE:SNY) announced that the license and development agreement between Sanofi and kaléo, formerly Intelliject Inc., the developer of Auvi-Q® (epinephrine injection, USP), will terminate later this year. At that time, all U.S. and Canadian rights will be returned to kaléo. Sanofi is in discussions with kaléo on these terms and for an orderly transition plan. Kaléo will evaluate timing and options for bringing Auvi-Q back to market.

Sanofi SA (ADR) (NYSE:SNY) shares advanced 3.23% in last trading session and ended the day at $40.30. SNY Gross Margin is 68.70% and its return on assets is 9.50%. Sanofi SA (ADR) (NYSE:SNY) quarterly performance is -8.16%.

Leave a Reply

Your email address will not be published. Required fields are marked *